| Immune modulation by multifaceted cationic host defense (antimicrobial) peptides AL Hilchie, K Wuerth, REW Hancock Nature chemical biology 9 (12), 761-768, 2013 | 710 | 2013 |
| New mouse model for chronic infections by Gram-negative bacteria enabling the study of anti-infective efficacy and host-microbe interactions D Pletzer, SC Mansour, K Wuerth, N Rahanjam, REW Hancock MBio 8 (1), e00140-17, 2017 | 130 | 2017 |
| The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E DR Namjoshi, G Martin, J Donkin, A Wilkinson, S Stukas, J Fan, M Carr, ... PloS one 8 (1), e53529, 2013 | 67 | 2013 |
| New insights into cathelicidin modulation of adaptive immunity K Wuerth, REW Hancock European journal of immunology 41 (10), 2817-2819, 2011 | 56 | 2011 |
| Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection KC Wuerth, R Falsafi, REW Hancock PloS one 12 (11), e0187565, 2017 | 35 | 2017 |
| COVID-19 in homeless populations: unique challenges and opportunities B Conway, D Truong, K Wuerth Future Virology 15 (6), 331-334, 2020 | 32 | 2020 |
| Characterization of host responses during Pseudomonas aeruginosa acute infection in the lungs and blood and after treatment with the synthetic immunomodulatory peptide IDR-1002 K Wuerth, AHY Lee, R Falsafi, EE Gill, REW Hancock Infection and immunity 87 (1), e00661-18, 2019 | 23 | 2019 |
| Identification of an IDR peptide formulation candidate that prevents peptide aggregation and retains immunomodulatory activity EF Haney, KC Wuerth, N Rahanjam, N Safaei Nikouei, A Ghassemi, ... Peptide Science 111 (1), e24077, 2019 | 15 | 2019 |
| Understanding Mobile Health and Youth Mental Health: Scoping Review X Ding, K Wuerth, B Sakakibara, J Schmidt, N Parde, L Holsti, S Barbic JMIR mHealth and uHealth 11, e44951, 2023 | 9 | 2023 |
| Combating Pseudomonas aeruginosa lung infections using synthetic host defense peptides K Wuerth University of British Columbia, 2017 | 4 | 2017 |
| Implementing Foundry: A cohort study describing the regional and virtual expansion of a youth integrated service in British Columbia, Canada S Barbic, E Mallia, K Wuerth, N Ow, K Marchand, S Ben‐David, A Ewert, ... Early Intervention in Psychiatry, 2024 | 3 | 2024 |
| 14 Immunomodulatory Activities of Cationic Host Defence Peptides and Novel Therapeutic Strategies KC Wuerth, REW Hancock Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies, 238, 2017 | 2 | 2017 |
| Host defence (antimicrobial) peptides and proteins KC Wuerth, AL Hilchie, KL Brown, REW Hancock eLS, 2013 | 2 | 2013 |
| Substance Use and Co-occurring Infections (Including Immunology) T Magel, K Wuerth, B Conway Textbook of Addiction Treatment, 1177-1190, 2021 | 1 | 2021 |
| Putting a roof over people’s heads: an important part of addressing HCV infection among people who inject drugs K Wuerth, L Yamamoto, B Conway Future Virology 15 (5), 253-255, 2020 | 1 | 2020 |
| Sofosbuvir and velpatasvir in the treatment of chronic hepatitis C K Wuerth, T Magel, B Conway Future Virology 14 (11), 715-727, 2019 | 1 | 2019 |
| Innate defence regulator peptide 1018 protects mice in the Pseudomonas aeruginosa acute lung infection model (P4045) A Hilchie, L Magrangeas-Janot, K Wuerth, R Hancock The Journal of Immunology 190 (1 Supplement), 131.23-131.23, 2013 | 1 | 2013 |
| Supporting young people through the COVID-19 pandemic and beyond: a multi-site qualitative longitudinal study M Whyte, E Nichol, LD Hawke, K Wuerth, M Quinlan-Davidson, A O’Reilly, ... BMC Health Services Research 24 (1), 1-21, 2024 | | 2024 |
